Latest Breaking News On - Sofinnova ventures - Page 1 : comparemela.com

Rapport s Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test

Rapport s Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesGoldman sachsRapport therapeuticsThird rock venturesJohnson innovationVenture partnersSofinnova ventures

Ascendis Pharma A/S : Form 6-K - MarketScreener

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K .

New zealandUnited kingdomUnited statesRepublic ofUnited arab emiratesRedwood cityHong kongSaudi arabiaRepublic of chinaTaiwan generalGreat britainSandoz gmbAscendis pharmaMichael wolff jensenBiopartners gmbEli lilly

Astria Therapeutics : - 2024 Proxy Statement

ASTRIA THERAPEUTICS, INC. 75 State Street, Suite 1400 Boston, MA 02109 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS .

United statesJoanne beckHugh coleJillc milneGregg lapointeWilmer cutler pickering haleMichael kishbauchSunil agarwalFred calloriErnst youngRoche holdings incBiology at cornell universityMyokardia incExchange commissionEquiniti trust companyCorporation law of the state delaware

Prothena Announces Appointment of Daniel G Welch as Director and Chair Designate

Prothena Announces Appointment of Daniel G Welch as Director and Chair Designate
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Anders harfstrandLars ekmanLarsg ekmanDanielg welchStructure therapeutics incGilead sciencesTriangle pharmaceuticals incNuvation bio incSeagen incProthena corporationUniversity of miamiCompany on twitter prothenacorpUniversity of north carolinaUltragenyx pharmaceuticals incRoche holdingsIntermune inc

Hinge Bio Expands Senior Management Team to Drive

Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge.

United statesVillanova schoolSan franciscoBarry selickCarin rollinsBiosciences labcorpSelina husain robert flammJoshua carleHarolde barry selickUniversity of californiaDaiichi sankyo incClearview projects incBurns mcclellan incBio incBusiness development at triumvira immunologics incPfizer inc